111 related articles for article (PubMed ID: 15334113)
1. Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.
Terunuma A; Ye J; Emmert S; Khan SG; Kraemer KH; Vogel JC
Gene Ther; 2004 Dec; 11(23):1729-34. PubMed ID: 15334113
[TBL] [Abstract][Full Text] [Related]
2. Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids.
Myrand SP; Topping RS; States JC
Carcinogenesis; 1996 Sep; 17(9):1909-17. PubMed ID: 8824513
[TBL] [Abstract][Full Text] [Related]
3. Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene.
Jones CJ; Lloyd RS; Wood RD
Mutat Res; 1994 Aug; 324(4):159-64. PubMed ID: 7519740
[TBL] [Abstract][Full Text] [Related]
4. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient.
Nouspikel T; Clarkson SG
Hum Mol Genet; 1994 Jun; 3(6):963-7. PubMed ID: 7951246
[TBL] [Abstract][Full Text] [Related]
5. Partial functional correction of xeroderma pigmentosum group A cells by suppressor tRNA.
Panchal RG; Wang S; McDermott J; Link CJ
Hum Gene Ther; 1999 Sep; 10(13):2209-19. PubMed ID: 10498252
[TBL] [Abstract][Full Text] [Related]
6. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients.
Miura M; Sasaki T
Mutat Res; 1996 Sep; 364(1):51-6. PubMed ID: 8814338
[TBL] [Abstract][Full Text] [Related]
7. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of a function of xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair.
Kobayashi T; Takeuchi S; Saijo M; Nakatsu Y; Morioka H; Otsuka E; Wakasugi M; Nikaido O; Tanaka K
Nucleic Acids Res; 1998 Oct; 26(20):4662-8. PubMed ID: 9753735
[TBL] [Abstract][Full Text] [Related]
9. Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA.
Yagi T; Matsumura Y; Sato M; Nishigori C; Mori T; Sijbers AM; Takebe H
Carcinogenesis; 1998 Jan; 19(1):55-60. PubMed ID: 9472693
[TBL] [Abstract][Full Text] [Related]
10. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
11. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
12. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
[TBL] [Abstract][Full Text] [Related]
13. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
14. Splice site mutations in a xeroderma pigmentosum group A patient with delayed onset of neurological disease.
States JC; Myrand SP
Mutat Res; 1996 Aug; 363(3):171-7. PubMed ID: 8765158
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.
Arlett CF; Plowman PN; Rogers PB; Parris CN; Abbaszadeh F; Green MH; McMillan TJ; Bush C; Foray N; Lehmann AR
Br J Radiol; 2006 Jun; 79(942):510-7. PubMed ID: 16714754
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
[TBL] [Abstract][Full Text] [Related]
17. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
18. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
Sato M; Nishigori C; Yagi T; Takebe H
Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
[TBL] [Abstract][Full Text] [Related]
19. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
20. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
